1. Home
  2. PTC vs MEDP Comparison

PTC vs MEDP Comparison

Compare PTC & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Inc.

PTC

PTC Inc.

HOLD

Current Price

$130.83

Market Cap

16.4B

Sector

Technology

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$589.64

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTC
MEDP
Founded
1985
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.4B
16.6B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
PTC
MEDP
Price
$130.83
$589.64
Analyst Decision
Buy
Hold
Analyst Count
11
12
Target Price
$183.09
$473.17
AVG Volume (30 Days)
1.1M
177.8K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
94.87
20.98
EPS
7.43
8.53
Revenue
$2,739,226,000.00
N/A
Revenue This Year
$0.03
$13.19
Revenue Next Year
$6.20
$7.75
P/E Ratio
$17.35
$68.73
Revenue Growth
19.18
N/A
52 Week Low
$108.50
$373.00
52 Week High
$208.56
$677.90

Technical Indicators

Market Signals
Indicator
PTC
MEDP
Relative Strength Index (RSI) 33.47 46.20
Support Level $110.53 $579.03
Resistance Level $147.08 $629.30
Average True Range (ATR) 4.63 14.13
MACD -3.87 -4.73
Stochastic Oscillator 5.33 8.19

Price Performance

Historical Comparison
PTC
MEDP

About PTC PTC Inc.

PTC is a US-based global company that offers high-end computer-assisted design, product lifecycle management, and augmented reality solutions that industrial manufacturers commonly use on factory floors. Founded in 1985, PTC is a major player in parametric design and serves some of the world's most well-known equipment manufacturers, such as Caterpillar, Garmin, and Thermo Fisher.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: